Tài liệu tham khảo |
Loại |
Chi tiết |
2. IMS Health. Development in cancer treatments, Market Dynamics, patient access and value-global oncology trend report 2015 |
Sách, tạp chí |
Tiêu đề: |
IMS Health. "Development in cancer treatments, Market Dynamics, patientaccess and value-global oncology trend report |
|
3. Brian Green, Michael D. Bentley, Bong Y. Chung, Nicholas G. Lynch, Bruce L.Jensen. Isolation of Betulin and Rearrangement to Allobetulin. ABiomimetic Natural Product Synthesis. Journal of Chemical Education, 2007, 84(12), p 1985 |
Sách, tạp chí |
Tiêu đề: |
Brian Green, Michael D. Bentley, Bong Y. Chung, Nicholas G. Lynch, BruceL.Jensen. "Isolation of Betulin and Rearrangement to Allobetulin. A"Biomimetic Natural Product Synthesis |
|
4. Alakurtti S, Mọkelọ T, Koskimies S, Yli-Kauhaluoma J. Pharmacological properties of the ubiquitous natural product betulin. European Journal of Pharmaceutical Sciences, 2006, 29(1), 1–13 |
Sách, tạp chí |
Tiêu đề: |
Alakurtti S, Mọkelọ T, Koskimies S, Yli-Kauhaluoma J. "Pharmacologicalproperties of the ubiquitous natural product betulin. "European Journal ofPharmaceutical Sciences, 2006 |
|
5. Yang X, Li Y, Jiang W, Ou M, Chen Y, Xu Y, Shao J. Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs. Chemical Biology & Drug Design, 2015, 86(6), 1397–1404 |
Sách, tạp chí |
Tiêu đề: |
Yang X, Li Y, Jiang W, Ou M, Chen Y, Xu Y, Shao J. "Synthesis andBiological Evaluation of Novel Ursolic acid Derivatives as PotentialAnticancer Prodrugs. "Chemical Biology & Drug Design, 2015 |
|
6. Bai KK, Yu Z, Chen FL, Li F, Li WY, Guo YH. Synthesis and evaluation of ursolic acid derivatives as potent cytotoxic agents. Bioorganic &Medicinal Chemistry Letters, 2012, 22(7), 2488–2493 |
Sách, tạp chí |
Tiêu đề: |
Bai KK, Yu Z, Chen FL, Li F, Li WY, Guo YH. "Synthesis and evaluationof ursolic acid derivatives as potent cytotoxic agents |
|
7. Weichert W, Denkert C, Noske A, Darb-Esfahani S, Dietel M, Kalloger SE, Huntsman DG, Kửbel M. Expression of Class I Histone Deacetylases Indicates Poor Prognosis in Endometrioid Subtypes of Ovarian and Endometrial Carcinomas. Neoplasia, 2008, 10, 1021-1027 |
Sách, tạp chí |
Tiêu đề: |
Weichert W, Denkert C, Noske A, Darb-Esfahani S, Dietel M, KallogerSE, Huntsman DG, Kửbel M. "Expression of Class I Histone DeacetylasesIndicates Poor Prognosis in Endometrioid Subtypes of Ovarian andEndometrial Carcinomas |
|
8. Ryan QC, Headlee D, Acharya M, Sparreboom A, Trepel JB, Ye J, Figg WD, Hwang K, Chung EJ, Murgo A, Melillo G, Elsayed Y, Monga M, Kalnitskiy M, Zwiebel J, Sausville EA. Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma. Journal of Clinical Oncology, 2005, 23, 3912-3922 |
Sách, tạp chí |
Tiêu đề: |
Ryan QC, Headlee D, Acharya M, Sparreboom A, Trepel JB, Ye J, FiggWD, Hwang K, Chung EJ, Murgo A, Melillo G, Elsayed Y, Monga M,Kalnitskiy M, Zwiebel J, Sausville EA. "Phase I and pharmacokineticstudy of MS-275, a histone deacetylase inhibitor, in patients withadvanced and refractory solid tumors or lymphoma |
|
10. Zhu P, Martin E, Mengwasser J, Schlag P, Janssen KP, Gửttlicher M.Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell, 2004, 5, 455-463 |
Sách, tạp chí |
Tiêu đề: |
Induction of HDAC2 expression upon loss of APC in colorectaltumorigenesis |
|
11. Arrowsmith CH, Bountra C, Fish PV, Lee K, Schapira M. Epigenetic protein families: a new frontier for drug discovery. Nature Reviews Drug Discovery, 2012, 11, 384-400 |
Sách, tạp chí |
Tiêu đề: |
Epigeneticprotein families: a new frontier for drug discovery |
|
13. Munster PN, Troso-Sandoval.T, RossenN, Rifkind R, Marks PA, Richon VM. Histone deacetylase inhibitors sensitize tumour cells for cytotoxic effects of natural killer cells. Cancer Res, 2001, 61, 8492-8497 |
Sách, tạp chí |
Tiêu đề: |
Histone deacetylase inhibitors sensitize tumour cells for cytotoxiceffects of natural killer cells |
|
14. Mottamal M, Zheng S, Huang TL, Wang G . Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents.Molecules, 2015, 20(3), 3898-3941 |
Sách, tạp chí |
Tiêu đề: |
Histone deacetylaseinhibitors in clinical studies as templates for new anticancer agents |
|
15. US Food and Drug Administration. FDA approves Beleodaq to treat rare, aggressive form of non-Hodgkin lymphoma [media release]. 2014;TopoTarget a S. FDA grants orphan drug status for belinostat for the treatment of peripheral T-cell lymphoma (PTCL) [media release]. 9 Sept 2009. http://investor.topotarget.com/releasedetail. cfm? releaseid=531003 |
Sách, tạp chí |
Tiêu đề: |
FDA approves Beleodaq to treat rare,aggressive form of non-Hodgkin lymphoma [media release]. "2014;TopoTarget a S. "FDA grants orphan drug status for belinostat for thetreatment of peripheral T-cell lymphoma (PTCL) [media release] |
|
16. Qian DZ, Kato Y, Shabbeer S, Wei Y, Verheul HM, Salumbides B, Sanni T, Atadja P, Pili R. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589. Clin Cancer Res, 2006, 12(2), 634-42.; Laubach JP, Moreau P, San-Miguel JF, Richardson PG |
Sách, tạp chí |
Tiêu đề: |
Targeting tumor angiogenesis with histone deacetylaseinhibitors: the hydroxamic acid derivative LBH589 |
|
17. Tsepaeva OV, Nemtarev AV, Abdullin TI, Grigor’eva LR, Kuznetsova EV, Akhmadishina RA, Ziganshina LE, Cong HH, and Mironov VF . Design, synthesis, and cancer cell growth inhibitory activity of triphenylphosphonium derivatives of the triterpenoid betulin. Journal of Natural Products, 2017, 80 (8) , 2232-2239 |
Sách, tạp chí |
Tiêu đề: |
Design,synthesis, and cancer cell growth inhibitory activity oftriphenylphosphonium derivatives of the triterpenoid betulin". Journal ofNatural Products, 2017, "80 |
|
18. Patlolla JMR, Rao CV. Triterpenoids for cancer prevention and treatment:current status and future prospects. Curr Pharm Biotechnol, 2012, 13,147– 155 |
Sách, tạp chí |
Tiêu đề: |
Triterpenoids for cancer prevention and treatment:"current status and future prospects |
|
19. Thibeault D, Guthier C, Legault J, Bouchard J, Dufour P and Andre´Pichette. Synthesis and structure-activity relationship study of cytotoxic germanicane- and lupane-type 3β-O-monodesmosidic saponins starting from betulin. Bioorganic Med Chem, 2007, 15, 6144–6157 |
Sách, tạp chí |
Tiêu đề: |
Synthesis and structure-activity relationship study of cytotoxicgermanicane- and lupane-type 3β-O-monodesmosidic saponins startingfrom betulin |
|
20. Franziska B. Mullauer, J.H.K., Jan Paul Medema. Betulin is a potent anti- tumor agent that is enhanced by cholesterol. PLoS One, 2009, 4(4), e5361 |
Sách, tạp chí |
Tiêu đề: |
Betulin is a potent anti-tumor agent that is enhanced by cholesterol |
|
21. I-Chen Sun, Jing Kang Sen., Hui Kang Wang, L. Mark Cosentino, and Kuo-Hsiung Lee. Anti-AIDS agents. 32.1 Synthesis and anti-HIV activity of betulin derivatives. Bioorganic Med Chem Lett, 1998, 8, 1267–1272 |
Sách, tạp chí |
Tiêu đề: |
Anti-AIDS agents. 32.1 Synthesis and anti-HIV activityof betulin derivatives |
|
22. I-Chen Sun, Hui Kang Wang, Yoshiki Kashiwada, Jing-Kang Shen, L. Mark Cosentino, Chin-Ho Chen, Li-Ming Yang and Kuo-Hsiung Lee. Anti-AIDS agents. 34. Synthesis and structure-activity relationships of betulin derivatives as anti-HIV agents. J Med Chem, 1998, 41, 4648–4657 |
Sách, tạp chí |
Tiêu đề: |
Anti-AIDSagents. 34. Synthesis and structure-activity relationships of betulinderivatives as anti-HIV agents |
|
23. Kashiwada Y, Chiyo J, Ikeshiro Y, Nagao T, Okabe H, Cosentino LM, Fowkec K and Lee KH. 3,28-Di-O-(dimethylsuccinyl)-betulin isomers as anti-HIV agents. Bioorg Med Chem Lett, 2011, 11, 183–5 |
Sách, tạp chí |
Tiêu đề: |
3,28-Di-O-(dimethylsuccinyl)-betulin isomers asanti-HIV agents |
|